niacin

systematic review meta-analysis network meta-analysis

Select cardiovascular prevention All type of patient       niacinniacin (on top statin)niacin in associationother cholesterol lowering drugs niacin vs placebo or controlvs ezetimibe      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	Coronary event (10)cardiovascular events (9)All cause death (6)stroke (fatal and non fatal) (6)Coronary death (3)non cardiovascular death (3)Cardiovascular death (3)Death from cancer (2)Non fatal MI (2)cardiac death (1) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	Coronary event	cardiovascular events
cardiovascular prevention
niacin
VA drugs, 1968	niacin	control			Low risk of bias	negative
UCSF SCOR, 1990	niacin+colestipol	control			Exploratory	negative
Carlson (Stockholm), 1977	clofibtate+niacin	placebo	secondary prevention		Risk of bias	suggesting
CLAS, 1987	colestipol-niacin	placebo	secondary prevention		Exploratory	negative
CDP niacin, 1975	niacin	placebo			Low risk of bias	suggesting
FATS, 1990	niacin+colestipol	placebo			Low risk of bias	suggesting
AIM-HIGH, 2011      NCT	niacin	placebo (on top statin)			Low risk of bias	negative
HPS 2-Thrive      NCT	niacin	placebo (on top statin)			Low risk of bias	negative
Oxford Niaspan Study, 2009    NCT	niacin	placebo (on top statin)			Exploratory	-
ARBITER 2, 2009	niacin	placebo (on top statin)			Exploratory	negative
HATS, 2001	niacin	placebo (on top statin)			Low risk of bias	negative
ARBITER 6-HALTS (niacin vs ezetimibe), 2009        NCT	niacin	ezetimibe			Exploratory	suggesting
Guyton, 2008	niacin+ezetimibe	simvastatin+ezetimibe			Low risk of bias	negative